Login / Signup

Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.

Luca QuartuccioGiorgia GregoraciMiriam IsolaSalvatore De Vita
Published in: Geriatrics & gerontology international (2018)
MTX up to 20 mg/day was useful in defined subsets of polymyalgia rheumatica, also in the long term. No significant differences were noticed among the five subgroups. Geriatr Gerontol Int 2018; 18: 1410-1414.
Keyphrases
  • high dose
  • giant cell
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • low dose
  • randomized controlled trial
  • peritoneal dialysis
  • prognostic factors
  • patient reported